A phase II study of active specific immunotherapy and5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma

Active specific immunotherapy, using vaccines with autologous tumour cells and BCG, significantly reduces the rate of tumour recurrence in stage II colon cancer patients, while no clinical benefit has yet been observed in stage III patients. Adjuvant treatment with 5-Fluorouracil/Leucovorin is now c...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Baars, A, Claessen, A M E, Wagstaff, J, Giaccone, G, Scheper, R J, Meijer, S, Schakel, M J A G, Gall, H E, Meijer, C J L M, Vermorken, J B, Pinedo, H M, van den Eertwegh, A J M
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 2002
主題:
Clinical
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375342/
https://ncbi.nlm.nih.gov/pubmed/11953877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600254
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍